UBS Group’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-49,100
Closed -$3.19M 9991
2024
Q3
$3.19M Buy
+49,100
New +$3.15M ﹤0.01% 3525
2020
Q4
Sell
-24,600
Closed -$2.13M 8433
2020
Q3
$2.13M Buy
+24,600
New +$2.05M ﹤0.01% 2983
2018
Q3
Sell
-17,000
Closed -$1.84M 8009
2018
Q2
$1.84M Buy
+17,000
New +$1.83M ﹤0.01% 3250
2017
Q3
Sell
-20,500
Closed -$1.82M 7748
2017
Q2
$1.82M Buy
+20,500
New +$1.8M ﹤0.01% 3098

Other funds holding CRI

UBS Group's CRI Position: Q1 2026 in Review

UBS Group reduced its Carter's (CRI) stake by 21% in Q1 2026, selling an estimated $10.2M and leaving 1,069,836 shares worth $38.3M. The position accounts for 0.01% of the portfolio, ranked #1910.

UBS Group first reported a position in CRI in Q4 2014 and has held it in 46 quarters since. The position peaked at $87.5M in Q4 2024. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.

  • UBS Group held 1,069,836 shares of Carter's worth $38.3M as of Q1 2026.
  • UBS Group sold 279,941 Carter's shares in Q1 2026, an estimated $10.2M.
  • Carter's made up 0.01% of UBS Group's portfolio in Q1 2026, its #1910 holding.
  • UBS Group first reported a position in Carter's in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Carter's position peaked at $87.5M in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.